Development and Initial Validation of the PROMIS®-Plus-HF Profile Measure

Faraz Ahmad, Michael Anthony Kallen, Karen E. Schifferdecker, Kathleen L. Carluzzo, Susan Yount, Jill M. Gelow, Peter A. McCullough, Stephen E. Kimmel, Elliot S. Fisher, David Cella

Research output: Contribution to journalArticle

Abstract

Background Bringing together generic and heart failure (HF)-specific items in a publicly available, patient-reported outcome measure may facilitate routine health status assessment for improving clinical care and shared decision-making, assessing quality of care, evaluating new interventions, and comparing groups with different conditions. Methods and Results We performed a mixed-methods study to develop and validate the PROMIS®-Plus-HF (Patient-Reported Outcomes Measurement Information System®-Plus-Heart Failure) profile measure-a HF-specific instrument based on the generic PROMIS. We conducted 8 focus groups with 61 patients with HF and phone interviews with 10 HF clinicians. The measure was developed via an iterative process of reviewing existing PROMIS items and developing and testing new HF items. In a 600-patient sample, we estimated reliability (internal consistency; test-retest, with n=100 participants). We conducted validity analyses using Pearson r and Spearman ρ correlations with Kansas City Cardiomyopathy Questionnaire subscores. In a longitudinal sample, we performed responsiveness testing (paired t tests) with 75 patients with HF receiving interventions with expected health status improvement. The PROMIS-Plus-HF measure comprises 86 items (64 existing; 22 new) across 18 domains. Internal consistency reliability (Cronbach α) coefficients ranged from 0.52 to 0.96, with α≥0.70 in 12 of 17 domains. Test-retest intraclass correlation coefficients were ≥0.90. Correlations with Kansas City Cardiomyopathy Questionnaire subscores supported expected convergent ( r/ρ>0.60) and divergent validity ( r/ρ<0.30). In the longitudinal sample, 10 of 18 domains had improved ( P<0.05) scores from baseline to follow-up. Conclusions The PROMIS-Plus-HF profile measure-a complete assessment of physical, mental, and social health-exhibited good psychometric characteristics and may facilitate patient-centered care and research. Subsets of domains and items can be used depending on the clinical or research purpose.

Original languageEnglish (US)
Pages (from-to)e005751
JournalCirculation. Heart failure
Volume12
Issue number6
DOIs
StatePublished - Jun 1 2019

Fingerprint

Information Systems
Heart Failure
Cardiomyopathies
Health Status
Patient Reported Outcome Measures
Patient-Centered Care
Quality of Health Care
Focus Groups
Research
Psychometrics
Decision Making
Mental Health
Interviews

Keywords

  • decision-making
  • health status
  • heart failure
  • patient-reported outcome measures
  • quality of life

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Ahmad, Faraz ; Kallen, Michael Anthony ; Schifferdecker, Karen E. ; Carluzzo, Kathleen L. ; Yount, Susan ; Gelow, Jill M. ; McCullough, Peter A. ; Kimmel, Stephen E. ; Fisher, Elliot S. ; Cella, David. / Development and Initial Validation of the PROMIS®-Plus-HF Profile Measure. In: Circulation. Heart failure. 2019 ; Vol. 12, No. 6. pp. e005751.
@article{482c08f9847d49638c79da0faefeda5e,
title = "Development and Initial Validation of the PROMIS{\circledR}-Plus-HF Profile Measure",
abstract = "Background Bringing together generic and heart failure (HF)-specific items in a publicly available, patient-reported outcome measure may facilitate routine health status assessment for improving clinical care and shared decision-making, assessing quality of care, evaluating new interventions, and comparing groups with different conditions. Methods and Results We performed a mixed-methods study to develop and validate the PROMIS{\circledR}-Plus-HF (Patient-Reported Outcomes Measurement Information System{\circledR}-Plus-Heart Failure) profile measure-a HF-specific instrument based on the generic PROMIS. We conducted 8 focus groups with 61 patients with HF and phone interviews with 10 HF clinicians. The measure was developed via an iterative process of reviewing existing PROMIS items and developing and testing new HF items. In a 600-patient sample, we estimated reliability (internal consistency; test-retest, with n=100 participants). We conducted validity analyses using Pearson r and Spearman ρ correlations with Kansas City Cardiomyopathy Questionnaire subscores. In a longitudinal sample, we performed responsiveness testing (paired t tests) with 75 patients with HF receiving interventions with expected health status improvement. The PROMIS-Plus-HF measure comprises 86 items (64 existing; 22 new) across 18 domains. Internal consistency reliability (Cronbach α) coefficients ranged from 0.52 to 0.96, with α≥0.70 in 12 of 17 domains. Test-retest intraclass correlation coefficients were ≥0.90. Correlations with Kansas City Cardiomyopathy Questionnaire subscores supported expected convergent ( r/ρ>0.60) and divergent validity ( r/ρ<0.30). In the longitudinal sample, 10 of 18 domains had improved ( P<0.05) scores from baseline to follow-up. Conclusions The PROMIS-Plus-HF profile measure-a complete assessment of physical, mental, and social health-exhibited good psychometric characteristics and may facilitate patient-centered care and research. Subsets of domains and items can be used depending on the clinical or research purpose.",
keywords = "decision-making, health status, heart failure, patient-reported outcome measures, quality of life",
author = "Faraz Ahmad and Kallen, {Michael Anthony} and Schifferdecker, {Karen E.} and Carluzzo, {Kathleen L.} and Susan Yount and Gelow, {Jill M.} and McCullough, {Peter A.} and Kimmel, {Stephen E.} and Fisher, {Elliot S.} and David Cella",
year = "2019",
month = "6",
day = "1",
doi = "10.1161/CIRCHEARTFAILURE.118.005751",
language = "English (US)",
volume = "12",
pages = "e005751",
journal = "Circulation: Heart Failure",
issn = "1941-3297",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

Development and Initial Validation of the PROMIS®-Plus-HF Profile Measure. / Ahmad, Faraz; Kallen, Michael Anthony; Schifferdecker, Karen E.; Carluzzo, Kathleen L.; Yount, Susan; Gelow, Jill M.; McCullough, Peter A.; Kimmel, Stephen E.; Fisher, Elliot S.; Cella, David.

In: Circulation. Heart failure, Vol. 12, No. 6, 01.06.2019, p. e005751.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Development and Initial Validation of the PROMIS®-Plus-HF Profile Measure

AU - Ahmad, Faraz

AU - Kallen, Michael Anthony

AU - Schifferdecker, Karen E.

AU - Carluzzo, Kathleen L.

AU - Yount, Susan

AU - Gelow, Jill M.

AU - McCullough, Peter A.

AU - Kimmel, Stephen E.

AU - Fisher, Elliot S.

AU - Cella, David

PY - 2019/6/1

Y1 - 2019/6/1

N2 - Background Bringing together generic and heart failure (HF)-specific items in a publicly available, patient-reported outcome measure may facilitate routine health status assessment for improving clinical care and shared decision-making, assessing quality of care, evaluating new interventions, and comparing groups with different conditions. Methods and Results We performed a mixed-methods study to develop and validate the PROMIS®-Plus-HF (Patient-Reported Outcomes Measurement Information System®-Plus-Heart Failure) profile measure-a HF-specific instrument based on the generic PROMIS. We conducted 8 focus groups with 61 patients with HF and phone interviews with 10 HF clinicians. The measure was developed via an iterative process of reviewing existing PROMIS items and developing and testing new HF items. In a 600-patient sample, we estimated reliability (internal consistency; test-retest, with n=100 participants). We conducted validity analyses using Pearson r and Spearman ρ correlations with Kansas City Cardiomyopathy Questionnaire subscores. In a longitudinal sample, we performed responsiveness testing (paired t tests) with 75 patients with HF receiving interventions with expected health status improvement. The PROMIS-Plus-HF measure comprises 86 items (64 existing; 22 new) across 18 domains. Internal consistency reliability (Cronbach α) coefficients ranged from 0.52 to 0.96, with α≥0.70 in 12 of 17 domains. Test-retest intraclass correlation coefficients were ≥0.90. Correlations with Kansas City Cardiomyopathy Questionnaire subscores supported expected convergent ( r/ρ>0.60) and divergent validity ( r/ρ<0.30). In the longitudinal sample, 10 of 18 domains had improved ( P<0.05) scores from baseline to follow-up. Conclusions The PROMIS-Plus-HF profile measure-a complete assessment of physical, mental, and social health-exhibited good psychometric characteristics and may facilitate patient-centered care and research. Subsets of domains and items can be used depending on the clinical or research purpose.

AB - Background Bringing together generic and heart failure (HF)-specific items in a publicly available, patient-reported outcome measure may facilitate routine health status assessment for improving clinical care and shared decision-making, assessing quality of care, evaluating new interventions, and comparing groups with different conditions. Methods and Results We performed a mixed-methods study to develop and validate the PROMIS®-Plus-HF (Patient-Reported Outcomes Measurement Information System®-Plus-Heart Failure) profile measure-a HF-specific instrument based on the generic PROMIS. We conducted 8 focus groups with 61 patients with HF and phone interviews with 10 HF clinicians. The measure was developed via an iterative process of reviewing existing PROMIS items and developing and testing new HF items. In a 600-patient sample, we estimated reliability (internal consistency; test-retest, with n=100 participants). We conducted validity analyses using Pearson r and Spearman ρ correlations with Kansas City Cardiomyopathy Questionnaire subscores. In a longitudinal sample, we performed responsiveness testing (paired t tests) with 75 patients with HF receiving interventions with expected health status improvement. The PROMIS-Plus-HF measure comprises 86 items (64 existing; 22 new) across 18 domains. Internal consistency reliability (Cronbach α) coefficients ranged from 0.52 to 0.96, with α≥0.70 in 12 of 17 domains. Test-retest intraclass correlation coefficients were ≥0.90. Correlations with Kansas City Cardiomyopathy Questionnaire subscores supported expected convergent ( r/ρ>0.60) and divergent validity ( r/ρ<0.30). In the longitudinal sample, 10 of 18 domains had improved ( P<0.05) scores from baseline to follow-up. Conclusions The PROMIS-Plus-HF profile measure-a complete assessment of physical, mental, and social health-exhibited good psychometric characteristics and may facilitate patient-centered care and research. Subsets of domains and items can be used depending on the clinical or research purpose.

KW - decision-making

KW - health status

KW - heart failure

KW - patient-reported outcome measures

KW - quality of life

UR - http://www.scopus.com/inward/record.url?scp=85067453702&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067453702&partnerID=8YFLogxK

U2 - 10.1161/CIRCHEARTFAILURE.118.005751

DO - 10.1161/CIRCHEARTFAILURE.118.005751

M3 - Article

VL - 12

SP - e005751

JO - Circulation: Heart Failure

JF - Circulation: Heart Failure

SN - 1941-3297

IS - 6

ER -